Using RECIST criteria for tumor progression and disease response, the mean change in CEA for patients with progression was an increase in 19 ng/mL, compared to a change of –7.3 ng/mL in those with ...
Improving the AJCC/TNM staging for adenocarcinomas of the appendix: The prognostic impact of histologic grade. Background: The objective of the present investigation was to assess whether elevated pre ...
Helicobacter pylori infection and the risk of colorectal cancer: A meta-analysis of epidemiologic evidence. Background: Carcinoembryonic antigen (CEA) is a widely used tumor marker for surveillance in ...
A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...